Product logins

Find logins to all Clarivate products below.


Contrast Agents and Radiopharmaceuticals | Market Insights | Europe | 2019

Despite stringent reimbursement regulations and the ongoing safety controversy surrounding GBCAs, the European contrast agent and radiopharmaceutical market will exhibit slight growth through 2027, propelled by ASP hikes in the radiopharmaceutical space and the increasing demand for diagnostic imaging procedures for Europe’s aging population. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for contrast agents and radiopharmaceuticals in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Europe
The European TEO device market is projected to experience modest growth over the forecast period, driven by increasing adoption of minimally invasive procedures. The trend is further supported by…
Report
Sports Medicine Devices – Market Insights – Europe
The Europe sports medicine device market will grow modestly through 2034, driven by growing demand for sports medicine procedures, uptake of premium-priced products, increased availability and…